Tacrolimus versus narrowband ultraviolet b in the treatment of vitiligo: a clinical and laboratory evaluation

• Váldodahkkit: Moustafa A El Taieb (Dahkki), Emad F Kholef (Dahkki), Sara Moustafa (Dahkki), Essam Nada (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wolters Kluwer Medknow Publications, 2017-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background Etiopathogenesis of vitiligo is unclear. Immunological background has a role. Interleukin 17 (IL-17) may play a role in its pathogenesis. There is no standard treatment regimen for vitiligo; however, calcineurin inhibitors may be an effective treatment option. Objective The aim was to eva...